Contact Us

Life Technologies Corporation

5791 Van Allen Way
Carlsbad, California 92008 USA
P (760) 603-7200
F (760) 602-6500
www.lifetechnologies.com

Media Contacts

Full Media Contacts List

Farnaz Khadem

Life Technologies
Head of Corporate Communications and Public Relations
P (760) 603-7245

Mark Springer

Life Technologies
Technical Public Relations,
Molecular Biology
P (650) 638-6113

Tim Ingersoll

Life Technologies
Corporate Media Relations
P (760) 918-3883

Lauren Lum

Life Technologies
Technical Public Relations,
Cell Systems Division, Applied Markets
P (650) 638-6916

Kim Evans

Life Technologies
Corporate Communications | Social Media
P (760) 476-7816

Patty Zamora

Life Technologies
Technical Public Relations,
Genomics, DNA Sequencing
P (760) 476-7818

Eriko Takahata

Life Technologies
Communications, Japan

Vivian Lv

Life Technologies
Communications, Asia Pacific
Close

Licensing

Full Licensing List

Traci Libby

Life Technologies
Licensing & Collaborations
P (760) 603-6497

Vicki Singer

Life Technologies
Out-Licensing
P (541) 335-0306
Close

Investor Relations

Full Investor Relations List

Investor Relations

Life Technologies
P (760) 603-7208
Close

News

  • SOLiD 4 Announced

    Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade.

    Read All Close
  • LT & Ignite Institute

    Life Technologies and the Ignite Institute for Individualized Health for a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical power in North America.

    Read All Close
  • Q4 & FY09 Results

    Life Technologies today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

    Read All Close

Life (Common Stock)